AzTrials
AzTrials

StrokeSUPERBNCT02947776

Adjustment With Aphasia After Stroke: SUPERB

A study testing PEER and USUAL in people with Stroke and Aphasia, run by City, University of London at 5 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aims: This exploratory trial will: 1. Explore the feasibility of a definitive/phase III RCT on clinical and cost-effectiveness of peer-befriending for people with aphasia post-stroke. 2. Investigate psychological and social wellbeing outcomes of participants, significant others, and peer befrienders. 3. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Aphasia
What is being tested?
PEER and USUAL
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
5 sitesUnited Kingdom
Study dates
25 May 2017to 20 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants with aphasia:
  • Over 18;
  • Fluent premorbid users of English (confirmed by relative or self report);
  • Presence of aphasia due to stroke; and
  • Low levels of emotional distress (score of ≤2 on Depression Intensity Scale Circles). The latter will ensure that they do not require immediate level 2 or 3 psychological input. People who score 2 (which is also the median on DISCS) and who the MDT deems do not need stepping up or stepping up is not available, will still be eligible to take part.
  • Significant Others: each participant with aphasia will nominate one significant other, who is their closest confidant and who is over 18 years of age. If participants live alone their significant other should be someone that they see at least once a week.
  • Peer befrienders: will be people with mild-moderate aphasia (score score a minimum 5/10 for auditory comprehension and 5/10 for verbal expression in the Frenchay Aphasia Screening Test) who are over 18 years of age, are at least one year post-stroke

Who cannot join

  • Participants will be excluded if they have:
  • Other diagnoses affecting cognition or mental health (based on medical records for participants with aphasia and self-report for significant others and peer befrienders, as well as the GHQ-12 as a depression screen for peer befrienders: will be excluded if they score 3 or more);
  • Severe uncorrected visual or hearing problems (based on medical records for participants with aphasia and self-report for significant others and peer befrienders);
  • Severe or potentially terminal co-morbidities, on grounds of frailty (based on medical records for participants with aphasia and self-report for significant others and peer befrienders).
  • Participants with aphasia will also be excluded if they are:
  • Discharged to a geographical location outside the borough of the recruiting hospital.

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United Kingdom5 sites
  • The Royal London Hospital

    London, E1 1BB

  • Homerton University Hospital

    London, E9 6SR

  • University College London Hospital

    London, NW1 2BU

  • The Royal Free Hospital

    London, NW3 2QG

  • The National Hospital for Neurology and Neurosurgery

    London, WC1N 3BG

Other trials in United Kingdom

About this study

Official title: Adjustment Post Stroke and Aphasia: Supporting Psychological Wellbeing Through Peer Befriending

Aims: This exploratory trial will:

  1. Explore the feasibility of a definitive/phase III RCT on clinical and cost-effectiveness of peer-befriending for people with aphasia post-stroke.
  2. Investigate psychological and social wellbeing outcomes of participants, significant others, and peer befrienders.
  3. Explore the feasibility of a full economic evaluation of usual care + peer befriending versus usual care control.
Read more

Design: Single blind, mixed methods, parallel group phase II RCT comparing usual care + peer-befriending vs. usual care, starting at discharge from hospital. The study will deliver on four work packages: development phase; RCT; qualitative study; economic evaluation. Participants (n=60) will be assessed three times up to 10 months post-randomisation.

Outcome measures: Feasibility: feasibility of recruitment to definitive trial (proportion screened who meet criteria; proportion who consent; rate of consent); participant, significant other, peer befriender views on acceptability of procedures (qualitative study); number of missing/incomplete data on outcome measures; attrition rate at follow-up; potential value of conducting main trial using value of information analysis (economic evaluation); description of usual care; treatment fidelity of peer-befriending. Patient-reported outcomes will include mood, wellbeing, communication and social participation.

Benefits: Peer befriending may help avert some of the serious psychological consequences of stroke, and prevent the need for more complex and costly psychological therapies.

Read the detailed description

Background: Stroke and aphasia can have a profound impact on people's lives. Depression is a common sequel of stroke, with rates remaining high even one year after stroke at 33%. It is associated with worse rehabilitation outcomes, increased carer strain, increased healthcare utilisation, and higher mortality. A recent audit of clinical psychology services for people with mood problems post-stroke across 10 UK stroke services found that the most common outcome of mood assessment was monitoring and advice, with less than half of patients with low mood receiving psychological intervention. There is a pressing need to evaluate systematically interventions that aim to improve psychosocial wellbeing for people with stroke and aphasia.

Aims: SUPERB trial aims to evaluate the feasibility of a phase III trial on the clinical and cost-effectiveness of a stepped care model level 1 intervention, peer befriending, for people with aphasia. Specifically it will:

  1. Explore the feasibility of a definitive phase III randomised control trial (RCT) based on a) feasibility of recruitment and retention to the trial, b) acceptability of research procedures and outcome measures, c) acceptability of usual care + peer befriending vs. usual care control to participants, their significant others and peer support workers, d) documentation of usual care, e) treatment fidelity of peer befriending.
  2. Explore psychological and social well-being outcomes as outcomes in a definitive trial for a) people with aphasia receiving usual care + peer befriending versus usual care control, b) their significant others, and c) peer befrienders.
  3. Explore the feasibility of a full economic evaluation of usual care + peer befriending versus usual care control in a phase III RCT.

Intervention to be tested: The intervention group will receive peer befriending from stroke survivors with long-term aphasia who will be trained as peer befrienders. They will visit participants who have had a stroke more recently 6 times over a period of 3 months. An further 2 visits within the next 6 months will also be offered for a gradual transition to the end of the peer befriending. The schedule and nature of visits will be agreed between the pair at their first meeting. This meeting will also identify possible goals for the intervention e.g. to offer conversation, help with problem solving and social activities.

Methods: The overall study will last 3½ years and comprise a development phase (year 1) and a phase II RCT (years 2-3). The development phase will inform the intervention manual, the choice of outcome measures, fidelity practices and topic guides for participant interviews. This phase will be informed through a series of six workshops attended by six people with aphasia with experience of peer befriending. This will be followed by a pilot of the intervention, fidelity checking and all associated processes with 8 participants comparing usual care (n=4) with usual care + peer befriending (n=4).

The phase II RCT will be a single blind, mixed methods, parallel group design comparing usual care (n=30) with usual care + peer befriending (n=30) for people with aphasia post-stroke and low levels of psychological problems. Assessments and outcome measures for participants and significant others will be administered before randomisation with outcome measures re-administered at 4 and 10 months post-randomisation. Peer befrienders will complete outcome measures before training and after they have completed the visits for two participants. In addition, this RCT will include a qualitative study and a feasibility economic evaluation. The qualitative study will use semi-structured interviews of purposively sampled participants (n=20) and significant others (n=10) from both arms of the trial, and peer befrienders. The feasibility economic evaluation will utilise the EQ-5D and a stroke-adapted version of the CSRI.

Outcomes: RCT: feasibility of recruitment of participants to definitive trial (including proportion screened who meet criteria; proportion who consent; rate of consent); number of missing/incomplete data on outcome measures; attrition rate at follow-up; potential value of conducting main trial using value of information analysis (economic evaluation); description of usual care; treatment fidelity of peer befriending. Patient-reported outcomes will include mood, wellbeing, communication and social participation. Qualitative study: participant, significant other, peer befriender views on acceptability of procedures and experiences of care received. Economic evaluation: cost outcomes, average costs, costs per participant and mean difference between trial arms, description of resources used and overall cost effectiveness.

Benefits: This study will inform on whether peer befriending is a suitable intervention to explore further, in terms of averting some of the serious psychological consequences of stroke, and preventing the need for more complex and costly psychological therapies.

Conditions
Stroke, Aphasia
Being tested
PEER, USUAL
Medical subject headings
Stroke, Aphasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PEERBehavioural

    The experimental group will receive usual care + peer befriending. Peer befriending aims to utilise the skills and 'lived experience' of people with longer-term aphasia to offer support to others with aphasia, starting at a time of transition (discharge from hospital and withdrawal of intensive therapeutic input) and increased need. It aims to help people develop their own strategies for adjusting to life post-stroke. Peer-befrienders will visit participants 6 times over a period of 3 months (+2 times within the next 6 months). The schedule, nature of visits, and goals (e.g. discuss concerns; pursue activities) will be agreed between the pair. Visits may include: conversation, problem solving, trips out, joint activities.

  • USUALBehavioural

    The control group will receive usual care, i.e. all health, social care and voluntary services available to them in their borough. It is not known what exactly usual care comprises for people with aphasia who are discharged in the community with low levels of psychological problems, and this project will help to document this.

Study groups in NCT02947776
Study groupRoleWhat they receive
USUALActive comparatorUsual care
Receives: Behavioral: USUAL
PEERExperimentalUsual care + peer-befriending
Receives: Behavioral: PEER; Behavioral: USUAL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. General Health Questionnaire-12 (GHQ-12) continuous total score

    For participants with aphasia.

    Measured: 4 months post randomisation

  2. Depression Intensity Scale Circles (DISCS) continuous total score

    The DISCS will be treated as the primary outcome measure only if there is ≥10% missing data in the GHQ-12 due to severity of aphasia, otherwise it will be a secondary outcome measure.

    Measured: 4 months post randomisation

  3. General Health Questionnaire-12 (GHQ-12) continuous total score

    For participants with aphasia.

    Measured: 10 months post randomisation

  4. Depression Intensity Scale Circles (DISCS) continuous total score

    The DISCS will be treated as the primary outcome measure only if there is ≥10% missing data in the GHQ-12 due to severity of aphasia, otherwise it will be a secondary outcome measure.

    Measured: 10 months post randomisation

Secondary outcomes (16)
  1. Short Warwick Edinburgh Mental Well-being Scale (SWEMWBS) continuous total score.

    For participants with aphasia.

    Measured: 4 months post randomisation

  2. Short Warwick Edinburgh Mental Well-being Scale (SWEMWBS) continuous total score.

    For participants with aphasia.

    Measured: 10 months post randomisation

  3. Communicative Participation Item Bank (CPIB) continuous total score

    For participants with aphasia.

    Measured: 4 months post randomisation

  4. Communicative Participation Item Bank (CPIB) continuous total score

    For participants with aphasia.

    Measured: 10 months post randomisation

  5. Community Integration Questionnaire (CIQ) continuous total score

    For participants with aphasia.

    Measured: 4 months post randomisation

  6. Community Integration Questionnaire (CIQ) continuous total score

    For participants with aphasia.

    Measured: 10 months post randomisation

  7. Proportion with high emotional distress vs low emotional distress as measured using the GHQ-12 (high distress = score of 3 or more, low distress = score of 0-2)

    For participants with aphasia.

    Measured: 4 months post randomisation

  8. Proportion with high emotional distress vs low emotional distress as measured using the GHQ-12 (high distress = score of 3 or more, low distress = score of 0-2)

    For participants with aphasia.

    Measured: 10 months post randomisation

  9. Warwick Edinburgh Mental Well-being Scale (WEMWBS) continuous total score

    For significant others.

    Measured: 4 months post randomisation

  10. Warwick Edinburgh Mental Well-being Scale (WEMWBS) continuous total score

    For significant others.

    Measured: 10 months post randomisation

  11. General Health Questionnaire-28 (GHQ-28) continuous total score. The GHQ-28 also provides four subscale scores (somatic symptoms, anxiety/insomnia, severe depression, and social dysfunction), which will be looked at descriptively.

    For significant others.

    Measured: 4 months post randomisation

  12. General Health Questionnaire-28 (GHQ-28) continuous total score. The GHQ-28 also provides four subscale scores (somatic symptoms, anxiety/insomnia, severe depression, and social dysfunction), which will be looked at descriptively.

    For significant others.

    Measured: 10 months post randomisation

  13. Bakas Caregiving Outcome Scale (BCOS) continuous total score

    For significant others.

    Measured: 4 months post randomisation

  14. Bakas Caregiving Outcome Scale (BCOS) continuous total score

    For significant others.

    Measured: 10 months post randomisation

  15. Warwick Edinburgh Mental Well-being Scale (WEMWBS) continuous total score

    For peer befrienders. Outcomes will be assessed on completion of 2 befriending cycles

    Measured: ~ 6 months

  16. Community Integration Questionnaire (CIQ) continuous total score

    For peer befrienders. Outcomes will be assessed on completion of 2 befriending cycles

    Measured: ~ 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2016 (estimated)
  2. Study start25 May 2017
  3. Primary completion20 Aug 2019
  4. Study completion20 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02947776
Sponsor's protocol ID
Staff/16-17/06
Acronym
SUPERB
Status last verified
Jan 2020
First submitted
13 Oct 2016
Last updated
22 Jul 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymised data may be shared e.g. for meta-analyses

Publications

  • Hilari K, Behn N, Marshall J, Simpson A, Thomas S, Northcott S, Flood C, McVicker S, Jofre-Bonet M, Moss B, James K, Goldsmith K. Adjustment with aphasia after stroke: study protocol for a pilot feasibility randomised controlled trial for SUpporting wellbeing through PEeR Befriending (SUPERB). Pilot Feasibility Stud. 2019 Jan 22;5:14. doi: 10.1186/s40814-019-0397-6. eCollection 2019.

    PubMed 30693094
  • Behn N, Moss B, McVicker S, Roper A, Northcott S, Marshall J, Thomas S, Simpson A, Flood C, James K, Goldsmith K, Hilari K. SUpporting wellbeing through PEeR-Befriending (SUPERB) feasibility trial: fidelity of peer-befriending for people with aphasia. BMJ Open. 2021 Aug 2;11(8):e047994. doi: 10.1136/bmjopen-2020-047994.

    PubMed 34341046
  • Moss B, Behn N, Northcott S, Monnelly K, Marshall J, Simpson A, Thomas S, McVicker S, Goldsmith K, Flood C, Hilari K. "Loneliness can also kill:" a qualitative exploration of outcomes and experiences of the SUPERB peer-befriending scheme for people with aphasia and their significant others. Disabil Rehabil. 2022 Sep;44(18):5015-5024. doi: 10.1080/09638288.2021.1922519. Epub 2021 Jun 4.

    PubMed 34086521
  • Northcott S, Behn N, Monnelly K, Moss B, Marshall J, Thomas S, Simpson A, McVicker S, Flood C, Goldsmith K, Hilari K. "For them and for me": a qualitative exploration of peer befrienders' experiences supporting people with aphasia in the SUPERB feasibility trial. Disabil Rehabil. 2022 Sep;44(18):5025-5037. doi: 10.1080/09638288.2021.1922520. Epub 2021 May 23.

    PubMed 34027757
  • Hilari K, Behn N, James K, Northcott S, Marshall J, Thomas S, Simpson A, Moss B, Flood C, McVicker S, Goldsmith K. Supporting wellbeing through peer-befriending (SUPERB) for people with aphasia: A feasibility randomised controlled trial. Clin Rehabil. 2021 Aug;35(8):1151-1163. doi: 10.1177/0269215521995671. Epub 2021 Feb 24.

    PubMed 33624514

Questions about this trial

What is this clinical trial studying?

A study testing PEER and USUAL in people with Stroke and Aphasia, run by City, University of London at 5 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

General Health Questionnaire-12 (GHQ-12) continuous total score (time frame: 4 months post randomisation). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02947776, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in